Title
De neonatale hielprikscreening: monitor 2018 [The newborn blood spot screening in the Netherlands: monitor 2018]
Author
van der Ploeg, C.P.B.
Wins, S.
Verkerk, P.H.
Publication year
2019
Abstract
The Newborn Blood Spot screening programme (NBS) was introduced in the Netherlands in 1974. The programme is coordinated by the Centre for Population Screening (CvB) of the National Institute for Public Health and the Environment (RIVM). The aim of the NBS is the early detection of certain serious congenital disorders in newborns. Children with these (rare) disorders benefit from early interventions such as medication or a diet, which can prevent or limit irreparable health damage. The national monitor with main results of the NBS is carried out annually by TNO at the request of the RIVM-CvB. The monitor enables insight into the functioning of all aspects of the NBS as well as insight into a possible need for extra measures to allow for an improvement in functioning of the screening program.
De deelnamegraad was boven de 99 procent. De deelname is sinds 2013 met 0,3 procent gedaald. Dit komt vooral doordat ouders iets vaker bezwaar maken tegen deelname. Ook wordt de hielprik wat vaker in het buitenland uitgevoerd. Recent is de PANDA-studie gestart, waarin onder andere onderzocht wordt waarom ouders ervoor kiezen wel of niet deel te nemen. Er zijn 524 kinderen verwezen vanuit de hielprikscreening (0,3%). Van hen hadden 145 (28% van de 524 verwezen kinderen en 0,086% van totaal aantal deelnemers) een van de aandoeningen waarop gescreend wordt.
Subject
ELSS - Earth, Life and Social Sciences
Human Performances
Healthy Living
Healthy for Life
Hielprik
Screening
Neonatale
CH - Child Health
To reference this document use:
http://resolver.tudelft.nl/uuid:dc51ef3a-6261-4abd-8814-f238366f535e
TNO identifier
873318
Report number
TNO 2019 R11521 TNO 2020 R10016
Publisher
TNO, Leiden
Document type
report